Your session is about to expire
← Back to Search
New Organic Infant Formula for Healthy Growth
Study Summary
This trial aims to show that a new formula for babies grows them as well as existing cow's milk formula, and compares to breastfeeding too.
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- You are a single person.A competent and willing caregiver must sign the IRB approved informed consent document.You have a caregiver who is willing to abide by the protocol demands (e.gYou are an infant aged 11 days or younger at the time of enrollment.Your baby is currently taking prescribed medication.You or a family member (parent or sibling) are allergic to cow's milk protein, except for lactose intolerance.Your baby has taken medications that can affect their growth, digestion, or development.You have experienced a healthy gestation period of between 37 and 41 weeks, 6 days.Your birth weight was between 2,500 grams and 4,500 grams.You are a caregiver who has made the choice to solely feed your infant formula or breast milk and is eager to maintain this feeding method during the research.The baby has health problems since birth, such as issues with the brain or body movement.You or a family member (grandparent, parent, sibling) has a known disorder related to how the body processes folate.The baby is not growing or gaining weight properly, has a fever, or has any problems related to their digestive system, such as acid reflux or a shortened gut. They also have any birth defects or health conditions that may affect their feeding or growth.
- Group 1: New Organic Infant Formula
- Group 2: Commercial Organic Infant Formula
- Group 3: Breastfed Reference Group
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Who is eligible to be part of this scientific research?
"The trial, which has a total capacity of 335 participants, is seeking infants between 0 Days and 11 Days old who present no health issues."
Does this trial encompass people of all ages, or is the age limit set at 50?
"This medical study is enrolling minors who are younger than 11 Days of age and have surpassed their 0 Day birthday."
Is this experiment currently open to participants?
"According to information on clinicaltrials.gov, this particular clinical trial is not presently recruiting patients. The initial post was made March 1st 2023 and the last edit occurred 23rd of March in the same year. Nevertheless, there are still one other trials currently enrolling volunteers at this moment."
Share this study with friends
Copy Link
Messenger